Paper8314022
Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells.
Pugliese G and 9 others. Diabetes, 1994. Cited by 118 papers, by iCite.
Cite this record
ConductScience Library. Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Papers, record 8314022. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8314022
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Extracellular Matrix | Major topic |
| Extracellular Matrix Proteins | Major topic |
| Glomerular Mesangium | Major topic |
| Glucose | Major topic |
| Animals | |
| Cell Division | |
| Cells, Cultured | |
| Collagen | |
| DNA | |
| Fibronectins | |
| Fructose | |
| Immunoenzyme Techniques | |
| Inositol | |
| Lactates | |
| Lactic Acid | |
| Laminin | |
| Polymers | |
| Pyruvates | |
| Pyruvic Acid | |
| Rats | |
| Rats, Sprague-Dawley |
Source PubMed
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 118 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39265079 | Glucagon receptor activation contributes to the development of kidney injury. | Am J Physiol Renal Physiol | 2024 | https://conductscience.org/library/papers/39265079 | PubMed |
| 34577791 | The Aggressive Diabetic Kidney Disease in Youth-Onset Type 2 Diabetes: Pathogenetic Mechanisms and Potential Therapies. | Medicina (Kaunas) | 2021 | https://conductscience.org/library/papers/34577791 | PubMed |
| 34512957 | A primer on metabolic memory: why existing diabesity treatments fail. | Clin Kidney J | 2021 | https://conductscience.org/library/papers/34512957 | PubMed |
| 32832011 | Understanding Diabetic Neuropathy: Focus on Oxidative Stress. | Oxid Med Cell Longev | 2020 | https://conductscience.org/library/papers/32832011 | PubMed |
| 28396584 | A high-glucose diet affects Achilles tendon healing in rats. | Sci Rep | 2017 | https://conductscience.org/library/papers/28396584 | PubMed |
| 27490532 | Serum Concentrations of Endothelin-1 and Matrix Metalloproteinases-2, -9 in Pre-Hypertensive and Hypertensive Patients with Type 2 Diabetes. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27490532 | PubMed |
| 27376090 | Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology. | J Diabetes Res | 2016 | https://conductscience.org/library/papers/27376090 | PubMed |
| 26446642 | All-Trans Retinoic Acid Has a Potential Therapeutic Role for Diabetic Nephropathy. | Yonsei Med J | 2015 | https://conductscience.org/library/papers/26446642 | PubMed |
| 25566460 | Type 2 Diabetes: Endothelial dysfunction and Exercise. | J Exerc Nutrition Biochem | 2014 | https://conductscience.org/library/papers/25566460 | PubMed |
| 24843470 | Polyol pathway and diabetic nephropathy revisited: Early tubular cell changes and glomerulopathy in diabetic mice overexpressing human aldose reductase. | J Diabetes Investig | 2011 | https://conductscience.org/library/papers/24843470 | PubMed |
| 24615213 | Effects of herbal compound 861 on collagen synthesis and degradation in rat mesangial cells exposed to high glucose. | Chin J Integr Med | 2014 | https://conductscience.org/library/papers/24615213 | PubMed |
| 23254483 | Matrix metalloproteinase (MMP-2, -9) and tissue inhibitor (TIMP-1, -2) activity in tear samples of pediatric type 1 diabetic patients: MMPs in tear samples from type 1 diabetes. | Graefes Arch Clin Exp Ophthalmol | 2013 | https://conductscience.org/library/papers/23254483 | PubMed |
| 22673147 | Renal protection of in vivo administration of tempol in streptozotocin-induced diabetic rats. | J Pharmacol Sci | 2012 | https://conductscience.org/library/papers/22673147 | PubMed |
| 22513850 | RNA-binding protein IGF2BP2/IMP2 is required for laminin-β2 mRNA translation and is modulated by glucose concentration. | Am J Physiol Renal Physiol | 2012 | https://conductscience.org/library/papers/22513850 | PubMed |
| 21030723 | Oxidative stress and diabetic complications. | Circ Res | 2010 | https://conductscience.org/library/papers/21030723 | PubMed |
| 20462972 | The role of epigenetics in the pathology of diabetic complications. | Am J Physiol Renal Physiol | 2010 | https://conductscience.org/library/papers/20462972 | PubMed |
| 19581401 | MicroRNAs and their role in progressive kidney diseases. | Clin J Am Soc Nephrol | 2009 | https://conductscience.org/library/papers/19581401 | PubMed |
| 19283512 | Functional polymorphisms of matrix metallopeptidase-9 and risk of coronary artery disease in a Chinese population. | Mol Biol Rep | 2010 | https://conductscience.org/library/papers/19283512 | PubMed |
| 14968292 | Redox state-dependent and sorbitol accumulation-independent diabetic albuminuria in mice with transgene-derived human aldose reductase and sorbitol dehydrogenase deficiency. | Diabetologia | 2004 | https://conductscience.org/library/papers/14968292 | PubMed |
| 11415460 | Fatty acids inhibit growth-factor-induced diacylglycerol kinase alpha activation in vascular smooth-muscle cells. | Biochem J | 2001 | https://conductscience.org/library/papers/11415460 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8314022
GET https://conductscience.org/api/papers/v1/8314022/cited_by?page=2